Anke L. Stuurman - Concepedia

Author

Anke L. Stuurman

Also Known As

A Stuurman, A. Stuurman, Anke L Stuurman, Anke L. Stuurman, Anke Stuurman, Stuurman, Anke L.

Publications

966

Citations

H-Index

Concepts

All Affiliations

Anke L. Stuurman is an author at GlaxoSmithKline (Belgium).

Anke L. Stuurman

Publications

499

Citations

H-Index

Page 1

	Year	Citations
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods Cheryl Gibbons, Marie‐Josée J. Mangen, Arie H. Havelaar, BMC Public Health	2014	393
Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom Corinne Willame, Dominique Rosillon, Julia Zima, Human Vaccines & Immunotherapeutics	2016	51
Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment Anke L. Stuurman, Margarita Riera-Montes, Smaragda Lamprianou, Vaccine	2018	22
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project Anke L. Stuurman, Miriam Levi, Philippe Beutels, Influenza and Other Respiratory Viruses	2022	13
Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink Germano Ferreira, Anke L. Stuurman, Yves Horsmans, European Journal of Gastroenterology & Hepatology	2019	10
Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe Anke L. Stuurman, Caterina Rizzo, Mendel Haag PLoS ONE	2021	10

Page 1